🌟 Meet "Rosie" - our new @pacbio.bsky.social Vega sequencer! Named after Rosalind Franklin, she'll supercharge our ProfilAIR & GenotypAIR services with faster, more comprehensive B & T cell receptor profiling. Better data = better biomarkers, faster vaccine design, and more precise therapeutics!

Thrilled to be featured in GenomeWeb! 🧬

Stuck behind the paywall? We got you. Here's the TL;DR on how Clareo is pioneering the next generation of immune profiling with full-length antibody sequencing.

Find it here: lnk.bio/clareobio

#Biotech #Genomics #LongReads #Immunology

Check out this week's newsletter, featuring @clareobio.bsky.social!

If you want to learn more about how Clareo Bio is changing the game with comprehensive immune profiling, come Ask Me Anything at the @pacbio.bsky.social suite at 10am! #AGBTGM

Genotype matters. At #AGBT25, Melissa Smith explores how germline-targeted immunogens and IGH variation impact immune response. Highly accurate #PacBio long reads help reveal critical insights for immunogenomics and precision medicine. #AGBTGM

Current AIRR-seq methods have limitations. At #AGBT25, Melissa Smith showcases how #PacBio highly accurate long reads provide the resolution needed to fully understand immune responses—paving the way for better immunotherapy and precision genomic medicine. #AGBTGM

Melissa Smith just delivered an incredible talk on how #HiFisequencing is transforming immune response research and vaccine innovation. Have more questions? Stop by our hospitality suite (Lanai #289) tomorrow at 10 AM for an AMA with Melissa! #AGBT #PacBio #AGBT25

Tomorrow’s the day! Catch Melissa Smith, PhD, live at #AGBT as she discusses how #PacBio #HiFisequencing is changing the game in immune response and vaccine research. You won’t want to miss this! #AGBT25

tap... tap... this thing on? Excited to be at #AGBTGM introducing @clareobio.bsky.social foundational data and services, sponsored by @pacbio.bsky.social. Clearly they saved the best talk for last! Come by and learn all about our comprehensive solutions to adaptive immune profiling.